Goserelin studies: 119 papers with results
Page 2 of 3
Goserelin has 1,014 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P · Fertility and sterility · 1993
Randomized controlled trial · 5 results
- Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection.
Montgomery BS · Prostate cancer and prostatic diseases · 2005
Randomized controlled trial · 2 results
- A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion.
Soysal ME · Human reproduction (Oxford, England) · 2001
Randomized controlled trial · 2 results
- Effect of androgen suppression compared with androgen receptor blockade on arterial stiffness in men with prostate cancer.
Dockery F · Journal of andrology · 2009
Randomized controlled trial · 8 results
- Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
Costantini S · European journal of obstetrics, gynecology, and reproductive biology · 1990
Randomized controlled trial · 3 results
- Similar frequency of testosterone surge after repeat injections of goserelin (Zoladex) 3.6 mg and 10.8 mg: results of a randomized open-label trial.
Zinner NR · Urology · 2004
Randomized controlled trial · 7 results
- Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
Lemay A · Clinical endocrinology · 1991
Randomized controlled trial · 10 results
- Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome.
West CP · Human reproduction (Oxford, England) · 1994
Randomized controlled trial · 7 results
- Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study.
Kvorning T · American journal of physiology. Endocrinology and metabolism · 2006
Randomized controlled trial · 4 results
- Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans.
Kvorning T · The Journal of physiology · 2007
Randomized controlled trial · 7 results
- The activity of satellite cells and myonuclei following 8 weeks of strength training in young men with suppressed testosterone levels.
Kvorning T · Acta physiologica (Oxford, England) · 2015
Randomized controlled trial · 7 results
- Pharmacological hypogonadism impairs molecular transducers of exercise-induced muscle growth in humans.
Gharahdaghi N · Journal of cachexia, sarcopenia and muscle · 2022
Randomized controlled trial · 16 results
- Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Davidson NE · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2005
Randomized controlled trial · 1 result
- Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.
Sverrisdottir A · Breast cancer research and treatment · 2009
Randomized controlled trial · 5 results
- Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study.
Berglund G · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2001
Randomized controlled trial · 3 results
- Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.
Peeling WB · Urology · 1989
Randomized controlled trial · 5 results
- Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study.
Boccardo F · Annals of oncology : official journal of the European Society for Medical Oncology · 1994
Randomized controlled trial · 2 results
- Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.
Nystedt M · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2003
Randomized controlled trial · 2 results
- The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy.
Leather AT · Obstetrics and gynecology · 1993
Randomized controlled trial · 4 results
- Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
Hackshaw A · Journal of the National Cancer Institute · 2009
Randomized controlled trial · 4 results
- A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.
Donnez J · Fertility and sterility · 2003
Randomized controlled trial · 4 results
- The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
Leather AT · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 1999
Randomized controlled trial · 2 results
- Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.
Karlsson P · Annals of oncology : official journal of the European Society for Medical Oncology · 2011
Randomized controlled trial · 4 results
- Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
Johansson A · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
Randomized controlled trial · 3 results
- Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study.
Benagiano G · Fertility and sterility · 1996
Randomized controlled trial · 7 results
- Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction.
Dhont M · Human reproduction (Oxford, England) · 1995
Randomized controlled trial · 7 results
- Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.
Sverrisdottir A · Breast cancer research and treatment · 2011
Randomized controlled trial · 2 results
- Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study.
Donnez J · Fertility and sterility · 1997
Randomized controlled trial · 7 results
- Health related quality of life using serum testosterone as the trigger to re-dose long acting depot luteinizing hormone-releasing hormone agonists in patients with prostate cancer.
Oefelein M · The Journal of urology · 2003
Non-randomized trial · 8 results
- Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.
Lawton CA · International journal of radiation oncology, biology, physics · 2001
Non-randomized trial · 8 results
- Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
Vercellini P · Acta obstetricia et gynecologica Scandinavica · 1993
Non-randomized trial · 5 results
- Gonadotropin releasing hormone agonist treatment before hysteroscopic endometrial resection.
Vercellini P · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 1994
Non-randomized trial · 3 results
- Laparoscopic aspiration of ovarian endometriomas. Effect with postoperative gonadotropin releasing hormone agonist treatment.
Vercellini P · The Journal of reproductive medicine · 1992
Non-randomized trial · 2 results
- A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.
Lind MJ · British journal of cancer · 1992
Non-randomized trial · 6 results
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment.
Paoletti AM · Fertility and sterility · 1996
Non-randomized trial · 3 results
- Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
Filicori M · The Journal of clinical endocrinology and metabolism · 1993
Non-randomized trial · 11 results
- High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
Simberg N · The Journal of clinical endocrinology and metabolism · 1996
Non-randomized trial · 4 results
- Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
Dodin S · Obstetrics and gynecology · 1991
Non-randomized trial · 15 results
- Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
West CP · Human reproduction (Oxford, England) · 1992
Non-randomized trial · 1 result
- Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.
Dahlgren E · Human reproduction (Oxford, England) · 1998
Non-randomized trial · 5 results
- Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
Jonat W · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2002
Non-randomized trial · 7 results
- Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
Sverrisdóttir A · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2004
Non-randomized trial · 2 results
- Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial.
Green HJ · BJU international · 2004
Non-randomized trial · 2 results
- Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade.
Sutherland JS · Clinical cancer research : an official journal of the American Association for Cancer Research · 2008
Non-randomized trial · 5 results
- Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer.
Kaufmann M · European journal of cancer (Oxford, England : 1990) · 2003
Non-randomized trial · 6 results
- A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer.
Jonat W · European journal of cancer (Oxford, England : 1990) · 1995
Non-randomized trial · 4 results
- Goserelin versus leuprolide in the chemical castration of patients with prostate cancer.
Dias Silva É · International urology and nephrology · 2012
Non-randomized trial · 6 results
- Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer.
Dockery F · Clinical endocrinology · 2008
Non-randomized trial · 4 results
- Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.
Souhami L · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2009
Observational study · 3 results
- Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids.
Lumsden MA · Fertility and sterility · 1989
Observational study · 1 result